Improved risk prediction of chemotherapy‐induced neutropenia—model development and validation with real‐world data

Improved risk prediction of chemotherapy‐induced neutropenia—model development and validation with real‐world data

Abstract Background The existing risk prediction models for chemotherapy‐induced febrile neutropenia (FN) do not necessarily apply to real‐life patients in different healthcare systems and the external validation of these models are often lacking. Our study evaluates whether a machine learning‐based...

Full description

Bibliographic Details
Main Authors: Mikko S. Venäläinen, Eetu Heervä, Outi Hirvonen, Sohrab Saraei, Tomi Suomi, Toni Mikkola, Maarit Bärlund, Sirkku Jyrkkiö, Tarja Laitinen, Laura L. Elo
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Cancer Medicine
Subjects:
chemotherapy
clinical decision support
granulocyte colony‐stimulating factor
machine learning
neutropenia
Online Access:https://doi.org/10.1002/cam4.4465

Internet

https://doi.org/10.1002/cam4.4465

Similar Items